Depreciation of PULSE BIOSCIENCES, INC. from 31 Mar 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
PULSE BIOSCIENCES, INC. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2015 to 31 Dec 2025.
  • PULSE BIOSCIENCES, INC. Depreciation for the quarter ending 31 Dec 2025 was $89,000, a 51% decline year-over-year.
  • PULSE BIOSCIENCES, INC. Depreciation for the twelve months ending 31 Dec 2025 was $406,000, a 21% decline year-over-year.
  • PULSE BIOSCIENCES, INC. annual Depreciation for 2025 was $406,000, a 21% decline from 2024.
  • PULSE BIOSCIENCES, INC. annual Depreciation for 2024 was $512,000, a 5.5% decline from 2023.
  • PULSE BIOSCIENCES, INC. annual Depreciation for 2023 was $542,000, a 21% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

PULSE BIOSCIENCES, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $406,000 $89,000 -$91,000 -51% 01 Oct 2025 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q3 2025 $497,000 $100,000 $0 0% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $497,000 $100,000 $0 0% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $497,000 $117,000 -$15,000 -11% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $512,000 $180,000 -$27,000 -13% 01 Oct 2024 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q3 2024 $539,000 $100,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $539,000 $100,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $539,000 $132,000 -$3,000 -2.2% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $542,000 $207,000 -$23,000 -10% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $565,000 $100,000 -$100,000 -50% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2024 2024 Q3
Q2 2023 $665,000 $100,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024 2024 Q2
Q1 2023 $665,000 $135,000 -$25,000 -16% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $690,000 $230,000 +$63,000 +38% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $627,000 $200,000 +$100,000 +100% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $527,000 $100,000 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $527,000 $160,000 +$47,000 +42% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $480,000 $167,000 +$41,000 +33% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $439,000 $100,000 $0 0% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $439,000 $100,000 $0 0% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $439,000 $113,000 +$9,000 +8.7% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q4 2020 $430,000 $126,000 -$6,000 -4.5% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2023 2022 FY
Q3 2020 $436,000 $100,000 $0 0% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $436,000 $100,000 $0 0% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $436,000 $104,000 -$58,000 -36% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $494,000 $132,000 +$40,000 +43% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2022 2021 FY
Q3 2019 $454,000 $100,000 -$100,000 -50% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $554,000 $100,000 -$100,000 -50% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $654,000 $162,000 +$9,000 +5.9% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $645,000 $92,000 -$95,000 -51% 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2021 2020 FY
Q3 2018 $740,000 $200,000 +$100,000 +100% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $640,000 $200,000 +$175,000 +700% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $465,000 $153,000 +$129,000 +538% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019 2019 Q1
Q4 2017 $336,000 $187,000 +$164,000 +713% 01 Oct 2017 31 Dec 2017 10-K 16 Mar 2020 2019 FY
Q3 2017 $172,000 $100,000 +$75,000 +300% 01 Jul 2017 30 Sep 2017 10-Q 01 Nov 2018 2018 Q3
Q2 2017 $97,000 $25,000 +$1,000 +4.2% 01 Apr 2017 30 Jun 2017 10-Q 31 Jul 2018 2018 Q2
Q1 2017 $96,000 $24,000 +$2,000 +9.1% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q4 2016 $94,000 $23,000 +$3,000 +15% 01 Oct 2016 31 Dec 2016 10-K 14 Mar 2019 2018 FY
Q3 2016 $91,000 $25,000 +$14,000 +127% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $77,000 $24,000 +$14,000 +140% 01 Apr 2016 30 Jun 2016 10-Q 10 Aug 2017 2017 Q2
Q1 2016 $63,000 $22,000 +$12,000 +120% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 $51,000 $20,000 01 Oct 2015 31 Dec 2015 10-K 16 Mar 2018 2017 FY
Q3 2015 $11,000 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $10,000 01 Apr 2015 30 Jun 2015 10-Q 10 Aug 2016 2016 Q2
Q1 2015 $10,000 01 Jan 2015 31 Mar 2015 10-Q 27 Jun 2016 2016 Q1

PULSE BIOSCIENCES, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $406,000 -$106,000 -21% 01 Jan 2025 31 Dec 2025 10-K 19 Feb 2026 2025 FY
2024 $512,000 -$30,000 -5.5% 01 Jan 2024 31 Dec 2024 10-K 19 Feb 2026 2025 FY
2023 $542,000 -$148,000 -21% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $690,000 +$210,000 +44% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $480,000 +$50,000 +12% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $430,000 -$64,000 -13% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2023 2022 FY
2019 $494,000 -$151,000 -23% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2022 2021 FY
2018 $645,000 +$309,000 +92% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021 2020 FY
2017 $336,000 +$242,000 +257% 01 Jan 2017 31 Dec 2017 10-K 16 Mar 2020 2019 FY
2016 $94,000 +$43,000 +84% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019 2018 FY
2015 $51,000 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.